PDT

Tabnine to Showcase AI-Driven Software Development at Nvidia GTC 2024

Retrieved on: 
Wednesday, March 6, 2024
Engineering, AI, Nvidia, TEL, SDLC, Organization, PDT, Nvidia GTC, Environment

When: Tuesday, March 19 from 4:00-4:25 p.m. PDT

Key Points: 
  • When: Tuesday, March 19 from 4:00-4:25 p.m. PDT
    AI-driven software development is poised to transform the entire software development life cycle (SDLC).
  • Learn the challenges and solutions for AI-driven software development, including:
    How does the SDLC change when autonomous agents can handle some tasks?
  • You'll also learn practical AI-assisted software development techniques based on the experience of Tabnine, a company that serves millions of users with AI-powered code completion.
  • Tabnine will be onsite at Nvidia GTC 2024 at booth #G101.

No More XR: Atmoph Window Yo with AI Avatar Enters the Gaming Platform

Retrieved on: 
Wednesday, March 6, 2024
Netflix, AI, Stranger Things, Animal, ChatGPT, City, Kojima Productions, Tree, PDT, XR, Knowledge

KYOTO, Japan, March 06, 2024 (GLOBE NEWSWIRE) -- Atmoph Inc. (Location: Kyoto, CEO: Kyohi Kang) has launched pre-orders for Atmoph Window Yo.

Key Points: 
  • KYOTO, Japan, March 06, 2024 (GLOBE NEWSWIRE) -- Atmoph Inc. (Location: Kyoto, CEO: Kyohi Kang) has launched pre-orders for Atmoph Window Yo.
  • Take advantage of an exclusive 28% off discount available until March 14th (PDT).
  • Atmoph introduces Atmoph Window Yo, a new entertainment system that connects users to over 1,700 stunning views from around the world.
  • Atmoph Scope is the telescopic controller to get more out of your Atmoph Window Yo.

Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference

Retrieved on: 
Tuesday, February 27, 2024
EDT, PDT, Cancer, Conference

REDWOOD CITY, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will present a company overview at the TD Cowen 44th Annual Healthcare Conference on Tuesday, Mar.

Key Points: 
  • REDWOOD CITY, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will present a company overview at the TD Cowen 44th Annual Healthcare Conference on Tuesday, Mar.
  • 5, at 2:50 p.m. EDT (11:50 a.m. PDT) in Boston, Massachusetts.
  • A live webcast of the presentation will be available on the Events and Presentations page of Bolt’s website at www.boltbio.com.
  • Archived replays will be available for 30 days following the event.

Want an Exciting Career? Edison International Accepting Applications for Lineworker Scholarship Program Designed to Strengthen a Diverse Workforce

Retrieved on: 
Thursday, March 7, 2024
Other Energy, Utilities, Professional Services, Energy, DEI (Diversity, Equity and Inclusion), Other Education, Continuing, Training, Education, Transport, Edison International, Female, Los Angeles Trade–Technical College, SCE, PDT, Teaching, Transmission, Workforce, IBEW, Housing, Nursing

Applications for scholarships up to $25,000 are now being accepted for the 2024 Edison International Lineworker Scholarship Program .

Key Points: 
  • Applications for scholarships up to $25,000 are now being accepted for the 2024 Edison International Lineworker Scholarship Program .
  • Funded by Edison International shareholders and IBEW Local 47, this scholarship is focused on growing Black, Asian Pacific Islander, Native American and female representation in Southern California Edison’s skilled workforce.
  • “The Lineworker Scholarship Program opens the door to a rewarding and enriching career.”
    Launched in 2021, the program has awarded over 35 scholarships and has enhanced representation among the SCE skilled trade workforce.
  • SCE serves one of the country’s most diverse populations and strives to have a workforce that reflects the communities it serves.

Intel Corporation to Host Investor Webinar on New Segment Reporting

Retrieved on: 
Wednesday, March 6, 2024
Other Manufacturing, Technology, Finance, Semiconductor, Professional Services, Manufacturing, Software, Networks, Hardware, Ecosystem, Intel, PDT, AI

Intel Corporation today announced that it will hold an investor webinar at 1:30 p.m. PDT on April 2, 2024, to present the vision and financial framework for the Intel Foundry business, including the recast financials and new segment reporting structure aligned with its transition to an internal foundry model.

Key Points: 
  • Intel Corporation today announced that it will hold an investor webinar at 1:30 p.m. PDT on April 2, 2024, to present the vision and financial framework for the Intel Foundry business, including the recast financials and new segment reporting structure aligned with its transition to an internal foundry model.
  • The webinar will discuss the longer-term vision for the foundry business and the importance of establishing a foundry-like relationship between Intel Foundry, Intel's manufacturing organization, and Intel Products, its product business units, to drive greater transparency and accountability.
  • The company intends to file an 8-K with a recast of its historical financials into the new reporting structure prior to the investor webinar.
  • Intel will report its results in the new reporting structure beginning with its first-quarter 2024 results.

Sidus Space LizzieSat™ To Launch Today, March 4, 2024 on SpaceX’s Transporter-10 Rideshare Mission

Retrieved on: 
Monday, March 4, 2024
Satellite, Software, Hardware, Data Management, Engineering, Technology, Aerospace, Manufacturing, Vandenberg Space Force Base, PDT, Ridesharing, Partnership

Liftoff of the Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”) LizzieSat is targeted for a launch window that opens today, March 4, 2024 at 2:05 p.m. PDT.

Key Points: 
  • Liftoff of the Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”) LizzieSat is targeted for a launch window that opens today, March 4, 2024 at 2:05 p.m. PDT.
  • The satellite will launch as part of SpaceX’s Transporter-10 Rideshare mission from Space Launch Complex 4 East at Vandenberg Space Force Base in California.
  • "As we prepare to launch LizzieSat, our multi-mission Space Platform with a Purpose™, the launch signifies a momentous occasion not only for Sidus Space but also for the broader space industry.
  • This eagerly awaited occasion marks a significant milestone in Sidus Space's mission of Bringing Space Down to Earth™.

Marriott Vacations Worldwide to Participate in J.P. Morgan Gaming, Lodging, Restaurant & Leisure Management Access Forum

Retrieved on: 
Thursday, February 29, 2024
Casino, Gaming, Entertainment, General Entertainment, Other Travel, Lodging, Tourist Attractions, Destinations, Vacation, Travel, VAC, Marriott Vacations Worldwide, PDT, Restaurant

Marriott Vacations Worldwide Corporation (NYSE: VAC) today announced that John Geller, President and Chief Executive Officer, and Jason Marino, Executive Vice President and Chief Financial Officer, will participate in a live fireside chat at the 2024 J.P. Morgan Gaming, Lodging, Restaurant & Leisure Management Access Forum in Las Vegas, Nevada on Thursday, March 14, at 3:50 p.m. PDT.

Key Points: 
  • Marriott Vacations Worldwide Corporation (NYSE: VAC) today announced that John Geller, President and Chief Executive Officer, and Jason Marino, Executive Vice President and Chief Financial Officer, will participate in a live fireside chat at the 2024 J.P. Morgan Gaming, Lodging, Restaurant & Leisure Management Access Forum in Las Vegas, Nevada on Thursday, March 14, at 3:50 p.m. PDT.
  • To tune in to the live presentation, please visit ir.mvwc.com .
  • Following the session, a recording will be available.

Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship Program

Retrieved on: 
Thursday, February 29, 2024
University, Education, Health, Philanthropy, General Health, Hispanic, Training, Genetics, Foundation, Consumer, Continuing, SRPT, Duchenne, Duchenne muscular dystrophy, Therapy, Student, PDT, Diagnosis, Sibling, Nursing

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the official opening of Route 79, The Duchenne Scholarship Program for the 2024-2025 academic year.

Key Points: 
  • Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the official opening of Route 79, The Duchenne Scholarship Program for the 2024-2025 academic year.
  • “Sarepta is proud to announce the opening of Route 79, The Duchenne Scholarship Program for the 2024-2025 academic year.
  • Only applicants diagnosed with Duchenne or applicants who have a sibling diagnosed with Duchenne are eligible for the program.
  • Previous recipients of Route 79 scholarships may apply for the 2024 Scholarship Program, however, applicants may only receive a Route 79 scholarship up to four times.

State of Pet Dental Health: Significant Majority of U.S. Dogs and Cats Have Oral Health Issues

Retrieved on: 
Friday, February 16, 2024
Periodontal disease, Pet, Research, Pain, Dog, Dentistry, Banfield Pet Hospital, Waltham Petcare Science Institute, Prevalence, Health, Cat, PDT, Heart, Bleeding

VANCOUVER, Wash., Feb. 16, 2024 /PRNewswire/ -- This National Pet Dental Health Month, Banfield Pet Hospital – the nation's leading provider of preventive veterinary care and part of the Mars Veterinary Health family of practices – analyzed its data from more than 3 million pets seen at its 1,000+ hospital locations nationwide to gain insights on the state of pet dental health across the U.S., including breeds and states with the highest and lowest cases of oral health-related issues.

Key Points: 
  • Dental disease in pets is about so much more than bad breath – and a lot more common than most owners realize.
  • In 2023, 73% of dogs and 64% of cats seen at Banfield were diagnosed with dental-related issues.
  • Poor oral health can be associated with pain, excessive drooling, bleeding, and reluctance to eat or drink.
  • "Oral health is an integral part of a pet's overall health and wellbeing, and our veterinary teams are committed to partnering with pet owners to find the right professional and at-home care plan for each pet."

HealthVerity recognized in three 2023 Gartner® Hype Cycle™ reports

Retrieved on: 
Tuesday, February 13, 2024
AI, Research, FDA, Health, Gartner hype cycle, Analytics, RWD, EHR, Health information management, Ecosystem, PDT, Patient, Clinical trial, Disease, Privacy, Science, Publication, HCLS, Public, Pharmaceutical industry

PHILADELPHIA, Feb. 13, 2024 /PRNewswire/ -- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced that it was recognized in three of the July 2023 Gartner Hype Cycles titled: Hype Cycle for Life Science Clinical Development, 2023, Hype Cycle for Life Science Commercial Operations, 2023, and Hype Cycle for Healthcare Data, Analytics and AI, 2023. This is the second year in a row that the company has been recognized in all three of these Hype Cycles and the third consecutive year for Life Science Commercial Operations.

Key Points: 
  • Recognized for Life Science Clinical Development, Life Science Commercial Operations, and Healthcare Data, Analytics and AI
    PHILADELPHIA, Feb. 13, 2024 /PRNewswire/ -- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced that it was recognized in three of the July 2023 Gartner Hype Cycles titled: Hype Cycle for Life Science Clinical Development, 2023, Hype Cycle for Life Science Commercial Operations, 2023, and Hype Cycle for Healthcare Data, Analytics and AI, 2023.
  • HealthVerity offers patient data tokenization services with HealthVerity Identity Manager , a leading patient matching and identity resolution technology that is 10x more accurate than legacy tokenization technologies.
  • "We are excited to be recognized by Gartner in the Hype Cycle reports," said HealthVerity COO Andrew Goldberg.
  • We believe our inclusion in the Gartner Hype Cycle reports demonstrates the difference these solutions can have on advancing the science."